Royal Bank Of Canada Raises Acadia Healthcare Price Target to $28

Analysts cite improving execution and embedded EBITDA growth under management changes.

Feb. 26, 2026 at 4:21pm

Research analysts at Royal Bank Of Canada increased their price target on shares of Acadia Healthcare (NASDAQ:ACHC) from $17.00 to $28.00 and maintained an "outperform" rating on the stock. The new price target suggests a potential upside of 27.10% from the company's current trading price.

Why it matters

Acadia Healthcare is a leading provider of behavioral healthcare services in the United States. The increased price target from a major research firm signals optimism about the company's growth prospects and operational improvements under its current management team.

The details

Royal Bank Of Canada cited improving execution and embedded EBITDA growth as reasons for raising Acadia Healthcare's price target. The company reported Q4 revenue of $821.5 million, beating expectations, and EPS of $0.07, modestly exceeding consensus. Acadia also provided Q1 2026 EPS guidance of $0.25-$0.30, well above the $0.11 consensus.

  • Acadia Healthcare reported Q4 2025 results on February 26, 2026.
  • Royal Bank Of Canada issued the updated price target and rating on February 26, 2026.

The players

Acadia Healthcare

A publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee.

Royal Bank Of Canada

A major Canadian multinational investment bank and financial services company.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

The takeaway

The increased price target from Royal Bank Of Canada reflects growing confidence in Acadia Healthcare's operational improvements and growth potential in the behavioral healthcare industry. The company's strong Q4 results and optimistic guidance suggest it is navigating industry challenges effectively under its current leadership.